naloxone hydrochloride

Generic: naloxone hydrochloride

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name naloxone hydrochloride
Generic Name naloxone hydrochloride
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active Ingredients

naloxone hydrochloride 1 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1529
Product ID 51662-1529_11ffcd59-50e0-e296-e063-6294a90a9fb7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213209
Listing Expiration 2026-12-31
Marketing Start 2021-07-15

Pharmacologic Class

Classes
opioid antagonist [epc] opioid antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621529
Hyphenated Format 51662-1529

Supplemental Identifiers

RxCUI
1191250
UNII
F850569PQR

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name naloxone hydrochloride (source: ndc)
Generic Name naloxone hydrochloride (source: ndc)
Application Number ANDA213209 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 1 mg/mL
source: ndc
Packaging
  • 1 SYRINGE in 1 BOX (51662-1529-1) / 2 mL in 1 SYRINGE
  • 10 POUCH in 1 BOX (51662-1529-3) / 1 SYRINGE in 1 POUCH (51662-1529-2) / 2 mL in 1 SYRINGE
source: ndc

Packages (2)

51662-1529-1 1 SYRINGE in 1 BOX (51662-1529-1) / 2 mL in 1 SYRINGE 51662-1529-3 10 POUCH in 1 BOX (51662-1529-3) / 1 SYRINGE in 1 POUCH (51662-1529-2) / 2 mL in 1 SYRINGE

Ingredients (1)

naloxone hydrochloride (1 mg/mL)

Linked Drug Pages (1)

NALOXONE HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "11ffcd59-50e0-e296-e063-6294a90a9fb7", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1191250"], "spl_set_id": ["c72a60fb-196d-3f02-e053-2995a90ad906"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 BOX (51662-1529-1)  / 2 mL in 1 SYRINGE", "package_ndc": "51662-1529-1", "marketing_start_date": "20210715"}, {"sample": false, "description": "10 POUCH in 1 BOX (51662-1529-3)  / 1 SYRINGE in 1 POUCH (51662-1529-2)  / 2 mL in 1 SYRINGE", "package_ndc": "51662-1529-3", "marketing_start_date": "20220511"}], "brand_name": "NALOXONE HYDROCHLORIDE", "product_id": "51662-1529_11ffcd59-50e0-e296-e063-6294a90a9fb7", "dosage_form": "INJECTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51662-1529", "generic_name": "NALOXONE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NALOXONE HYDROCHLORIDE", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA213209", "marketing_category": "ANDA", "marketing_start_date": "20210715", "listing_expiration_date": "20261231"}